You are here

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF
PostScript
Letter
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?

https://doi.org/10.1136/ejhpharm-2021-002680

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Correction notice This article has been corrected since it first published. The provenance and peer review statement has been included.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles